原料药相关价格情况更新：2024年6月原料药相关价格情况

Investment Rating - The report maintains a "Positive" rating for the pharmaceutical and biotechnology industry [1] Core Views - The report provides an update on the price trends of active pharmaceutical ingredients (APIs) and related intermediates in June 2024 [2] Hormone Category Price Trends - In June 2024, the prices of saponin and diene in the hormone category increased by 3.45% and 2.00% month-on-month respectively, while prices of progesterone, medroxyprogesterone acetate, dexamethasone sodium phosphate, and hydrocortisone remained stable [5] - Year-on-year, saponin, dexamethasone sodium phosphate, and diene prices increased by 20.00%, 361.54%, and 13.33% respectively, while progesterone, hydrocortisone, and hydrocortisone acetate prices decreased by 7.32%, 1.72%, and 2.73% respectively [5][6] Antibiotic Intermediates Price Trends - In June 2024, 7-ACA, 6-APA, and penicillin industrial salt prices increased by 2.08%, 9.38%, and 36.36% month-on-month respectively, while 4-AA price decreased by 9.84% [7][8] - Year-on-year, 7-ADCA and 7-ACA prices increased by 4.00% and 8.89% respectively, while 6-APA, 4-AA, and penicillin industrial salt prices decreased by 5.41%, 36.05%, and 11.76% respectively [7][8] β-Lactam Antibiotics Price Trends - In June 2024, prices of cephalosporins and amoxicillin remained stable month-on-month [9] - Year-on-year, prices of ceftriaxone sodium, cefoperazone sodium, cefixime, cefaclor, and amoxicillin decreased by 4.76%, 10.91%, 12.50%, 9.52%, and 7.81% respectively [9][10] Cardiovascular Category Price Trends - In June 2024, prices of cardiovascular APIs such as valsartan, irbesartan, telmisartan, lisinopril, enalapril maleate, and atorvastatin calcium remained stable month-on-month [11] - Year-on-year, prices of valsartan, irbesartan, telmisartan, lisinopril, and atorvastatin calcium decreased by 11.56%, 2.34%, 4.55%, 10.42%, and 3.85% respectively, while enalapril maleate price remained stable [11][12]